HUMAN Diagnostics Launches Next Generation Clinical Chemistry Instruments
Posted on 04 Feb 2025
HUMAN Diagnostics (Wiesbaden, Germany) is launching its next-generation clinical chemistry instruments at Medlab Middle East 2025. The launch is under the motto “Primed for Precision. Built for Performance” and will spotlight the next-generation HumaStar 300SR, HumaStar 200, and the HumaLyzer Primus NG, offering laboratories cutting-edge performance, enhanced efficiency, and robust reliability. These instruments cater to diverse throughput needs, empowering labs to deliver accurate and timely results critical to patient care.
The updated HumaStar 300SR and HumaStar 200 instruments offer improved performance and reliability with an advanced cuvette wash station and, now new, clot detection (HumaStar 300SR only). The upgraded pipetting unit ensures higher precision for low volumes and better repeatability, while V-shaped reaction cuvettes reduce reagent use and operating costs. Additionally, an integrated 2D barcode scanner simplifies the import of QC and calibration target values, streamlining operations; the 3-color LED status illumination provides intuitive and easy monitoring.
The HumaLyzer Primus NG is a user-friendly, semi-automated solution that is ideal for laboratories in resource-limited settings with a large 7-inch touchscreen interface enhancing usability. Visitors to HUMAN’s booth can explore these next-gen instruments and view live demonstrations that showcase their capabilities and ease of use. Additionally, HUMAN is also showcasing the HumaCombilyzer portable, semi-automated urine test strip analyzer which is ideal for in-office and more rural healthcare settings. Alongside, HUMAN is showcasing HumaCombina urine test strips which enable fast and effortless assessment of urine status, supporting the detection of pathological changes.
“HUMAN’s clinical chemistry instruments have long been trusted for their precision and reliability. With this launch, we’re setting new standards for laboratory diagnostics by combining German engineering excellence with the latest technological advancements,” said Dr. Christine Hettmann-Dreuw, VP of Marketing & Strategic Purchase at HUMAN Diagnostics.